Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome

Transpl Int. 2014 Sep;27(9):e84-6. doi: 10.1111/tri.12304. Epub 2014 Mar 29.

Authors

Gabriele Catalano¹, Paolo De Simone, Alessandro Mazzoni, Davide Ghinolfi, Laura Coletti, Franco Filipponi

Affiliation

¹ Liver Transplantation Unit, Department of Oncology, Transplantation and New Technologies, Azienda Ospedaliero-Universitaria, Pisa, Italy. g.catalano@ao-pisa.toscana.it.

PMID: 24606320
DOI: 10.1111/tri.12304

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Blindness, Cortical / chemically induced*
Blood Group Incompatibility / drug therapy*
Blood Group Incompatibility / immunology
Calcineurin Inhibitors / adverse effects*
Calcineurin Inhibitors / therapeutic use
Carcinoma, Hepatocellular / etiology
Carcinoma, Hepatocellular / surgery
Confusion / chemically induced*
Drug Substitution
Drug Therapy, Combination
Emergencies
Everolimus
Graft Rejection / prevention & control*
Graft Rejection / therapy
Hepatitis B, Chronic / complications
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use*
Liver Cirrhosis / etiology
Liver Cirrhosis / surgery
Liver Neoplasms / etiology
Liver Neoplasms / surgery
Liver Transplantation* / adverse effects
Male
Middle Aged
Photopheresis
Plasmapheresis
Sirolimus / analogs & derivatives*
Sirolimus / therapeutic use
Syndrome
Tacrolimus / adverse effects*
Tacrolimus / therapeutic use

Substances

Calcineurin Inhibitors
Immunosuppressive Agents
Everolimus
Sirolimus
Tacrolimus